Related Experiment Video
Updated: Jun 11, 2025

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Noninvasive Respiratory Support for Pediatric Critical Asthma
Andrew G Miller1, Alexandre T Rotta2
1Mr. Miller is affiliated with Division of Pediatric Critical Care Medicine, Duke University Medical Center, Durham, North Carolina; Respiratory Care Services, Duke University Medical Center, Durham, North Carolina; and Thomas Jefferson University, Philadelphia, Pennsylvania.
Insights
Noninvasive respiratory support (NRS) aids severe pediatric asthma cases, but evidence is limited. This review examines NRS benefits and limitations to guide clinical decisions for better outcomes in critical asthma patients.
Area of Science:
- Pediatric Pulmonology
- Critical Care Medicine
- Respiratory Physiology
Background:
- Pediatric asthma frequently leads to emergency visits and hospitalizations.
- Severe cases, termed critical asthma, often necessitate noninvasive respiratory support (NRS) and intensive care.
- Current clinical practice relies heavily on observational data due to limited clinical trials.
Purpose of the Study:
- To review the current evidence on noninvasive respiratory support (NRS) in pediatric critical asthma.
- To explore the physiological rationale, practical considerations, and future research directions for NRS.
- To provide clinicians with a comprehensive overview for improved therapeutic decision-making.
Main Methods:
- Narrative review of existing literature on NRS in pediatric critical asthma.
- Analysis of physiological benefits of various NRS modalities (high-flow nasal cannula, CPAP, noninvasive ventilation).
- Evaluation of evidence supporting efficacy and limitations of NRS.
Main Results:
- NRS modalities offer physiological benefits like reduced work of breathing and enhanced gas exchange.
- Evidence supporting NRS efficacy in pediatric critical asthma is currently limited.
- Observational studies predominantly inform current clinical practice.
Conclusions:
- Noninvasive respiratory support (NRS) plays a role in managing pediatric critical asthma.
- Further robust clinical trials are needed to establish definitive efficacy and optimize use.
- A comprehensive understanding of NRS benefits and limitations is crucial for improving patient outcomes.
Abstract:
Pediatric asthma is a common cause of emergency department visits and hospital admissions. Whereas most patients respond well to standard pharmacologic treatments, those with more severe disease frequently require noninvasive respiratory support (NRS) and adjunct therapies or admission to an ICU-a condition termed critical asthma. NRS modalities include high-flow nasal cannula, CPAP, and noninvasive ventilation to deliver standard air-oxygen mixtures or helium-oxygen (heliox). Each NRS modality offers distinct physiological benefits, primarily aimed at reducing work of breathing, enhancing gas exchange, and optimizing aerosol delivery. Despite the growing use of NRS, robust evidence supporting its efficacy in pediatric critical asthma is limited, with few published clinical trials and a heavy reliance on observational studies to inform clinical practice. This narrative review explores the current evidence, physiological rationale, practical considerations, and future research directions for the use of NRS in pediatric critical asthma. The goal is to provide clinicians with a comprehensive overview of the benefits and limitations of NRS modalities to better inform therapeutic decisions and improve patient outcomes.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Acute Respiratory Failure-III
Inhaled Medications

